HMGCR and osteoporosis: More recently, Deng et al. have observed that the influence of γT3 on preventing ovariectomy-induced osteoporosis can be reversed by a daily administration of mevalonate, a HMG-CoA reductase inhibitor, in rats, indicating that γT3 prevents bone loss by inhibiting HMG-CoA reductase [131].